ATE277182T1 - Das nuca protein von haemophilus influenzae und dessen kodierender gen - Google Patents

Das nuca protein von haemophilus influenzae und dessen kodierender gen

Info

Publication number
ATE277182T1
ATE277182T1 AT97935048T AT97935048T ATE277182T1 AT E277182 T1 ATE277182 T1 AT E277182T1 AT 97935048 T AT97935048 T AT 97935048T AT 97935048 T AT97935048 T AT 97935048T AT E277182 T1 ATE277182 T1 AT E277182T1
Authority
AT
Austria
Prior art keywords
nuca
protein
influenzae
amino acid
acid sequence
Prior art date
Application number
AT97935048T
Other languages
English (en)
Inventor
Robert John Zagursky
Kevin Frederick Jones
Peggy Ooi
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/687,865 external-priority patent/US5955596A/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE277182T1 publication Critical patent/ATE277182T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AT97935048T 1996-07-26 1997-07-23 Das nuca protein von haemophilus influenzae und dessen kodierender gen ATE277182T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2261996P 1996-07-26 1996-07-26
US08/687,865 US5955596A (en) 1996-07-26 1996-07-26 NucA protein of Haemophilus influenzae and the gene encoding that protein
PCT/US1997/012790 WO1998004703A1 (en) 1996-07-26 1997-07-23 THE NucA PROTEIN OF HAEMOPHILUS INFLUENZAE AND THE GENE ENCODING THAT PROTEIN

Publications (1)

Publication Number Publication Date
ATE277182T1 true ATE277182T1 (de) 2004-10-15

Family

ID=26696143

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97935048T ATE277182T1 (de) 1996-07-26 1997-07-23 Das nuca protein von haemophilus influenzae und dessen kodierender gen

Country Status (10)

Country Link
US (1) US6221365B1 (de)
EP (1) EP0854925B1 (de)
JP (1) JP2001524803A (de)
AT (1) ATE277182T1 (de)
AU (1) AU729684B2 (de)
CA (1) CA2232975A1 (de)
DE (1) DE69730814T2 (de)
ES (1) ES2227709T3 (de)
PT (1) PT854925E (de)
WO (1) WO1998004703A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1146906B1 (de) * 1999-02-05 2011-07-06 Alk-Abelló A/S Mukosales verabreichungssytem
US7722861B2 (en) * 2002-02-19 2010-05-25 Svetoslav Bardarov, legal representative Attenuated Mycobacterium tuberculosis vaccines
US7758874B2 (en) * 2002-02-19 2010-07-20 Albert Einstein College Of Medicine Of Yeshiva University Attenuated Mycobacterium tuberculosis vaccines
WO2004066928A2 (en) * 2003-01-24 2004-08-12 Albert Einstein College Of Medicine Of Yeshiva University Use of mycobacterial vaccines in cd4+ or cd8+ lymphocyte-deficient mammals
US7428497B2 (en) * 2003-10-06 2008-09-23 Utbk, Inc. Methods and apparatuses for pay-per-call advertising in mobile/wireless applications
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP2425853A1 (de) 2005-04-08 2012-03-07 Wyeth LLC Multivalente Pneumokokken-Polysaccharidproteinkonjugatzusammensetzung
EP2351835B1 (de) * 2008-09-30 2016-03-30 Denka Seiken Co., Ltd. Verfahren zur herstellung gereinigter influenzavirus-antigene

Also Published As

Publication number Publication date
PT854925E (pt) 2004-12-31
ES2227709T3 (es) 2005-04-01
EP0854925B1 (de) 2004-09-22
WO1998004703A1 (en) 1998-02-05
AU729684B2 (en) 2001-02-08
DE69730814T2 (de) 2005-09-29
CA2232975A1 (en) 1998-02-05
EP0854925A1 (de) 1998-07-29
AU3807797A (en) 1998-02-20
JP2001524803A (ja) 2001-12-04
DE69730814D1 (de) 2004-10-28
US6221365B1 (en) 2001-04-24

Similar Documents

Publication Publication Date Title
RU2206611C2 (ru) ФРАГМЕНТ ДНК, ПЛАЗМИДНЫЙ ВЕКТОР, СПОСОБ ПОЛУЧЕНИЯ ПОЛИПЕПТИДА И ПОЛИПЕПТИД, ОБЛАДАЮЩИЙ IL-1β ПРОТЕАЗНОЙ АКТИВНОСТЬЮ
CA2230885A1 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
EP0330191A3 (de) CD40 kodierende DNA
RU2006105498A (ru) Полипептиды для индукции защитного иммунного ответа против staphylococcus aureus
CA2087272A1 (en) Cd53 cell surface antigen and use thereof
CA2354508A1 (en) Streptococcal c5a peptidase vaccine
IL95806A0 (en) The human c3b/c4b receptor(cr1)
CA2307842A1 (en) Hyaluronan synthase gene and uses thereof
DE506574T1 (de) Protein mit Cytokinaktivität, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.
CA2257839A1 (en) Gamma-heregulin
WO1998004702A3 (en) Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use
ES2014593A6 (es) Un metodo para preparar un vector de acido nucleico que codifica una proteina de cr1.
NZ334358A (en) isolated polypeptide comprising an immunogenic portion of a M vaccine antigen, use in the treatment and diagnosis of mycobacterial infections
OA09214A (en) Thermally stable cytosine deaminase.
DE69730814D1 (de) DAS NucA PROTEIN VON HAEMOPHILUS INFLUENZAE UND DESSEN KODIERENDER GEN
CA2252493A1 (en) .beta.-galactoside - .alpha. 2,6-sialyltransferase gene
CA2266421A1 (en) Genes coding for a protein having glycoside transfer activity
Egelseer et al. Characterization of an S-layer glycoprotein produced in the course of S-layer variation of Bacillus stearothermophilu s ATCC 12980 and sequencing and cloning of the sbsD gene encoding the protein moiety
Yoshikawa et al. Purification, characterization and gene cloning of a novel glutamic acid-specific endopeptidase from Staphylococcus aureus ATCC 12600
WO1991011462A3 (en) Merosin, nucleic acids encoding, fragments and uses thereof
EP0834568A3 (de) Speichel-bindendes Protein von Streptococcus pneumoniae
EP0273373A2 (de) Peptide und deren Produktion
MX9603876A (es) Procedimiento intermitente de digestion para producir pulpa deslignficada.
CA2223503A1 (en) Transferrin receptor genes
CA2301902A1 (en) Novel extracellular serine protease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0854925

Country of ref document: EP

REN Ceased due to non-payment of the annual fee